These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6485524

  • 1. [Transcutaneous oxygen pressure during intra-arterial infusions].
    Creutzig A, Dau D, Alexander K.
    Vasa; 1984; 13(3):207-12. PubMed ID: 6485524
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE.
    Med Welt; 1973 Jan 19; 24(3):103-13. PubMed ID: 4617835
    [No Abstract] [Full Text] [Related]

  • 3. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L, Landi A, Bársony J.
    Ther Hung; 1975 Jan 19; 23(2):54-9. PubMed ID: 1188703
    [No Abstract] [Full Text] [Related]

  • 4. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G, Majorana M.
    Clin Ter; 1983 Mar 15; 104(5):375-81. PubMed ID: 6303677
    [No Abstract] [Full Text] [Related]

  • 5. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D, Cameli AM, Trapani M, Dorigo D, Mazzotta A, Negro P.
    Clin Ter; 1987 Jun 30; 121(6):479-83. PubMed ID: 2973884
    [No Abstract] [Full Text] [Related]

  • 6. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G, Fabbri F, Benvenuti C.
    Clin Ter; 1983 Feb 28; 104(4):297-304. PubMed ID: 6861465
    [No Abstract] [Full Text] [Related]

  • 7. [Determinations of clinical variations and lipid metabolism in patients with chronic ischemia of the lower extremities by means of a pentosan sulfonic ester and xanthinol niacinate combination].
    González González M, Azcona Elizalde JM, Lorente Navarro MC, Duato Jane A.
    Angiologia; 1979 Feb 28; 31(4):180-4. PubMed ID: 382919
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T, Griesshaber J, Rogatti W, Kistner O, Hsu E, Jansen T, Diehm C.
    Vasa Suppl; 1991 Feb 28; 33():341-2. PubMed ID: 1788749
    [Abstract] [Full Text] [Related]

  • 9. [Use of xavin in vascular diseases of the lower extremities].
    Volgin EG.
    Klin Med (Mosk); 1980 Oct 28; 58(10):46-50. PubMed ID: 7442096
    [No Abstract] [Full Text] [Related]

  • 10. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G.
    Vasa Suppl; 1988 Oct 28; 23():121-5. PubMed ID: 3206330
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of a 3-month-interval running exercise in combination with vasodilative therapy on microcirculation of the lower leg in peripheral arterial circulation disorders (stage I and II)].
    Siewert H, Winterfeld HJ, Strangfeld D, Schmidt HH, Correns HJ.
    Z Alternsforsch; 1983 Oct 28; 38(5):377-81. PubMed ID: 6659566
    [Abstract] [Full Text] [Related]

  • 12. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G, Dupont T.
    Lille Med; 1976 Jan 28; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract] [Full Text] [Related]

  • 13. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP.
    Vestn Khir Im I I Grek; 1982 Sep 28; 129(9):120-3. PubMed ID: 7147583
    [No Abstract] [Full Text] [Related]

  • 14. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
    Fagrell B, Lundberg G, Olsson A, Ostergren J.
    Vasa; 1986 Sep 28; 15(1):56-60. PubMed ID: 3962459
    [No Abstract] [Full Text] [Related]

  • 15. Propranolol-induced reverse vascular steal in arteriopathic patients.
    Brevetti G, Chiariello M, Ferulano GP, Betocchi S, Paudice G, Lavecchia G, Abate S, Verrienti S, Condorelli M.
    Angiology; 1982 Feb 28; 33(2):78-89. PubMed ID: 7065457
    [No Abstract] [Full Text] [Related]

  • 16. [Intra-arterial therapy of arterial occlusive diseases of the extremities].
    Grossmann K, Knischka A.
    Z Arztl Fortbild (Jena); 1987 Feb 28; 81(17):879-82. PubMed ID: 3439204
    [No Abstract] [Full Text] [Related]

  • 17. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J, Heidrich H, Lammersen T.
    J Mal Vasc; 1987 Feb 28; 12(1):78-81. PubMed ID: 3559415
    [Abstract] [Full Text] [Related]

  • 18. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I, Molnár G.
    Ther Hung; 1973 Feb 28; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract] [Full Text] [Related]

  • 19. [Experiences with ultra-high dosage fibrinolysis in arterial occlusive disease].
    Redecker M, Heinrich F, Fenn K.
    Vasa Suppl; 1988 Feb 28; 23():182-5. PubMed ID: 3206334
    [No Abstract] [Full Text] [Related]

  • 20. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M, Gimeno Martínez J, Honorato J.
    Rev Clin Esp; 1976 Jul 31; 142(2):157-61. PubMed ID: 968103
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.